Session

Liver & biliary (Posters)

GALLBLADDER NEUROENDOCRINE CARCINOMAS ARISING IN A BACKGROUND OF BILIARY INTRAEPITHELIAL NEOPLASIA AND INTRACHOLECYSTIC PAPILLARY NEOPLASM SUGGEST MONOCLONAL ORIGIN
GALLBLADDER NEUROENDOCRINE CARCINOMAS ARISING IN A BACKGROUND OF BILIARY INTRAEPITHELIAL NEOPLASIA AND INTRACHOLECYSTIC PAPILLARY NEOPLASM SUGGEST MONOCLONAL ORIGIN

PREDICTORS OF ADVANCED FIBROSIS IN NAFLD: ONE MORE STEP TOWARDS NONINVASIVE ASSESSMENT
PREDICTORS OF ADVANCED FIBROSIS IN NAFLD: ONE MORE STEP TOWARDS NONINVASIVE ASSESSMENT

INDUCTION OF PROGRAMMED CELL DEATH (APOPTOSIS) IN HEPATOCELLULAR CARCINOMA BY USING A NOVEL COMBINATION OF PANOBINOSTAT AND BLEOMYCIN
INDUCTION OF PROGRAMMED CELL DEATH (APOPTOSIS) IN HEPATOCELLULAR CARCINOMA BY USING A NOVEL COMBINATION OF PANOBINOSTAT AND BLEOMYCIN

PHASE ANGLE AND CLINICAL OUTCOMES IN LIVER CIRRHOSIS
PHASE ANGLE AND CLINICAL OUTCOMES IN LIVER CIRRHOSIS

PREVALENCE, RISK FACTORS AND CLINICAL IMPACT OF MULTIDRUG-RESISTANT BACTERIAL COLONIZATION IN CIRRHOTIC PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT IN A SPANISH TERTIARY HOSPITAL
PREVALENCE, RISK FACTORS AND CLINICAL IMPACT OF MULTIDRUG-RESISTANT BACTERIAL COLONIZATION IN CIRRHOTIC PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT IN A SPANISH TERTIARY HOSPITAL

NONINVASIVE ASSESSMENT OF GRAFT STEATOSIS AND FIBROSIS AFTER LIVER TRANSPLANTATION BY TRANSIENT ELASTOGRAPHY
NONINVASIVE ASSESSMENT OF GRAFT STEATOSIS AND FIBROSIS AFTER LIVER TRANSPLANTATION BY TRANSIENT ELASTOGRAPHY

RISK OF OCCURRENCE AND RECURRENCE OF HEPATOCELLULAR CARCINOMA IN 349 PATIENTS WITH LIVER CIRRHOSIS AND HEPATITIS C VIRUS INFECTION GENOTYPE 1 B TREATED WITH SOFOSBUVIR+LEDIPASVIR_ RIBAVIRIN
RISK OF OCCURRENCE AND RECURRENCE OF HEPATOCELLULAR CARCINOMA IN 349 PATIENTS WITH LIVER CIRRHOSIS AND HEPATITIS C VIRUS INFECTION GENOTYPE 1 B TREATED WITH SOFOSBUVIR+LEDIPASVIR_ RIBAVIRIN

SERUM MIR-421 AND LNCRNA MEG3 AS BIOMARKERS FOR THE DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
SERUM MIR-421 AND LNCRNA MEG3 AS BIOMARKERS FOR THE DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN

OPTIMIZING SEQUENTIAL SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELULLAR CARCINOMA: A DECISION ANALYSIS
OPTIMIZING SEQUENTIAL SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELULLAR CARCINOMA: A DECISION ANALYSIS

A MURINE MODEL OF HEPATIC ENCEPHALOPATHY: VALIDATION AND NEUROBEHAVIORAL TESTING
A MURINE MODEL OF HEPATIC ENCEPHALOPATHY: VALIDATION AND NEUROBEHAVIORAL TESTING

ESTIMATED ANNUAL LIVER GROWTH PREDICTS NEED FOR TREATMENT IN POLYCYSTIC LIVER DISEASE
ESTIMATED ANNUAL LIVER GROWTH PREDICTS NEED FOR TREATMENT IN POLYCYSTIC LIVER DISEASE

REAL WORLD EFFICACY AND SAFETY OF SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS AND HEPATITIS C VIRUS INFECTION: A COHORT STUDY
REAL WORLD EFFICACY AND SAFETY OF SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS AND HEPATITIS C VIRUS INFECTION: A COHORT STUDY

NON-ALCOHOLIC FATTY LIVER DISEASE INVOLVES DEVIATIONS IN MICRORNAS AND HEMATOLOGICAL INDICES - A SINGLE CENTRE OBSERVATION
NON-ALCOHOLIC FATTY LIVER DISEASE INVOLVES DEVIATIONS IN MICRORNAS AND HEMATOLOGICAL INDICES - A SINGLE CENTRE OBSERVATION

A TREATMENT TO CONSIDER: MULTIVISCERAL TRANSPLANTATION FOR PORTO-MESENTERIC VENOUS THROMBOSIS
A TREATMENT TO CONSIDER: MULTIVISCERAL TRANSPLANTATION FOR PORTO-MESENTERIC VENOUS THROMBOSIS

PROGRESSION-FREE SURVIVAL IS A CONSISTENT SURROGATE ENDPOINT OF OVERALL SURVIVAL IN IMMUNOTHERAPY TRIALS OF ADVANCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS
PROGRESSION-FREE SURVIVAL IS A CONSISTENT SURROGATE ENDPOINT OF OVERALL SURVIVAL IN IMMUNOTHERAPY TRIALS OF ADVANCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS

DAY-4 LILLE SCORE IN EARLY PREDICTION OF CORTICOSTEROID RESPONSE FOR PATIENTS WITH SEVERE ACUTE ALCOHOLIC HEPATITIS
DAY-4 LILLE SCORE IN EARLY PREDICTION OF CORTICOSTEROID RESPONSE FOR PATIENTS WITH SEVERE ACUTE ALCOHOLIC HEPATITIS

SAFETY, EFFICACY AND COST-EFFECTIVENESS OF GLASGOW MODIFIED ALCOHOL WITHDRAWAL SCALE AND SYMPTOM-TRIGGERED DOSING REGIMEN FOR THE MANAGEMENT OF ACUTE ALCOHOL WITHDRAWAL SYNDROME IN AINTREE UNIVERSITY TEACHING HOSPITAL
SAFETY, EFFICACY AND COST-EFFECTIVENESS OF GLASGOW MODIFIED ALCOHOL WITHDRAWAL SCALE AND SYMPTOM-TRIGGERED DOSING REGIMEN FOR THE MANAGEMENT OF ACUTE ALCOHOL WITHDRAWAL SYNDROME IN AINTREE UNIVERSITY TEACHING HOSPITAL

NUTRITIONAL PATTERNS OF PATIENTS WITH NAFLD SIGNIFICANTLY DIFFER TO THOSE IN A CONTROL GROUP
NUTRITIONAL PATTERNS OF PATIENTS WITH NAFLD SIGNIFICANTLY DIFFER TO THOSE IN A CONTROL GROUP

MALNUTRITION AND MORTALITY RISK IN LIVER CIRRHOSIS PATIENTS
MALNUTRITION AND MORTALITY RISK IN LIVER CIRRHOSIS PATIENTS

LYMPHOCYTE TO MONOCYTE RATIO CAN BE A SIMPLE AND NOVEL PREDICTOR IN CIRRHOTIC PATIENTS WITH CULTURE NEGATIVE NEUTROCYTIC ASCITES
LYMPHOCYTE TO MONOCYTE RATIO CAN BE A SIMPLE AND NOVEL PREDICTOR IN CIRRHOTIC PATIENTS WITH CULTURE NEGATIVE NEUTROCYTIC ASCITES

Item 101 - 120 / 334
1 2 3 4 5
6
7 8 9 10 11 12 13 14 15 16 17